FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W578040726> ?p ?o ?g. }

• W578040726 endingPage "e1001833" @default.
• W578040726 startingPage "e1001833" @default.
• W578040726 abstract "Background Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. The ancillary Cognitive and Affective Study (KEEPS-Cog) of the Kronos Early Estrogen Prevention Study (KEEPS) examined the effects of up to 4 y of MHT on cognition and mood in recently postmenopausal women. Methods and Findings KEEPS, a randomized, double-blinded, placebo-controlled clinical trial, was conducted at nine US academic centers. Of the 727 women enrolled in KEEPS, 693 (95.3%) participated in the ancillary KEEPS-Cog, with 220 women randomized to receive 4 y of 0.45 mg/d oral conjugated equine estrogens (o-CEE) plus 200 mg/d micronized progesterone (m-P) for the first 12 d of each month, 211 women randomized to receive 50 μg/d transdermal estradiol (t-E2) plus 200 mg/d m-P for the first 12 d of each month, and 262 women randomized to receive placebo pills and patches. Primary outcomes included the Modified Mini-Mental State examination; four cognitive factors: verbal learning/memory, auditory attention/working memory, visual attention/executive function, and speeded language/mental flexibility; and a mood measure, the Profile of Mood States (POMS). MHT effects were analyzed using linear mixed-effects (LME) models, which make full use of all available data from each participant, including those with missing data. Data from those with and without full data were compared to assess for potential biases resulting from missing observations. For statistically significant results, we calculated effect sizes (ESs) to evaluate the magnitude of changes. On average, participants were 52.6 y old, and 1.4 y past their last menstrual period. By month 48, 169 (24.4%) and 158 (22.8%) of the 693 women who consented for ancillary KEEPS-Cog were lost to follow-up for cognitive assessment (3MS and cognitive factors) and mood evaluations (POMS), respectively. However, because LME models make full use all available data, including data from women with missing data, 95.5% of participants were included in the final analysis (n = 662 in cognitive analyses, and n = 661 in mood analyses). To be included in analyses, women must have provided baseline data, and data from at least one post-baseline visit. The mean length of follow-up was 2.85 y (standard deviation [SD] = 0.49) for cognitive outcomes and 2.76 (SD = 0.57) for mood outcomes. No treatment-related benefits were found on cognitive outcomes. For mood, model estimates indicated that women treated with o-CEE showed improvements in depression and anxiety symptoms over the 48 mo of treatment, compared to women on placebo. The model estimate for the depression subscale was −5.36 × 10−2 (95% CI, −8.27 × 10−2 to −2.44 × 10−2; ES = 0.49, p < 0.001) and for the anxiety subscale was −3.01 × 10−2 (95% CI, −5.09 × 10−2 to −9.34 × 10−3; ES = 0.26, p < 0.001). Mood outcomes for women randomized to t-E2 were similar to those for women on placebo. Importantly, the KEEPS-Cog results cannot be extrapolated to treatment longer than 4 y. Conclusions The KEEPS-Cog findings suggest that for recently postmenopausal women, MHT did not alter cognition as hypothesized. However, beneficial mood effects with small to medium ESs were noted with 4 y of o-CEE, but not with 4 y of t-E2. The generalizability of these findings is limited to recently postmenopausal women with low cardiovascular risk profiles. Trial Registration ClinicalTrials.gov NCT00154180 and NCT00623311" @default.
• W578040726 created "2016-06-24" @default.
• W578040726 creator A5007377929 @default.
• W578040726 creator A5007554920 @default.
• W578040726 creator A5020230532 @default.
• W578040726 creator A5020416642 @default.
• W578040726 creator A5030184373 @default.
• W578040726 creator A5040832215 @default.
• W578040726 creator A5042566253 @default.
• W578040726 creator A5044102386 @default.
• W578040726 creator A5047090122 @default.
• W578040726 creator A5067709976 @default.
• W578040726 creator A5068573040 @default.
• W578040726 creator A5069339514 @default.
• W578040726 creator A5073212927 @default.
• W578040726 creator A5074289517 @default.
• W578040726 creator A5079428284 @default.
• W578040726 creator A5079665496 @default.
• W578040726 creator A5080040826 @default.
• W578040726 creator A5087768424 @default.
• W578040726 creator A5089170421 @default.
• W578040726 date "2015-06-02" @default.
• W578040726 modified "2023-10-12" @default.
• W578040726 title "Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study" @default.
• W578040726 cites W1964606698 @default.
• W578040726 cites W1967596264 @default.
• W578040726 cites W1969680120 @default.
• W578040726 cites W1971457115 @default.
• W578040726 cites W1972963493 @default.
• W578040726 cites W1977374270 @default.
• W578040726 cites W1978061037 @default.
• W578040726 cites W1980616946 @default.
• W578040726 cites W1988575213 @default.
• W578040726 cites W1990899486 @default.
• W578040726 cites W1994127157 @default.
• W578040726 cites W1999631936 @default.
• W578040726 cites W2009374844 @default.
• W578040726 cites W2009733979 @default.
• W578040726 cites W2012080584 @default.
• W578040726 cites W2015034820 @default.
• W578040726 cites W2017079501 @default.
• W578040726 cites W2019175546 @default.
• W578040726 cites W2023651401 @default.
• W578040726 cites W2024413755 @default.
• W578040726 cites W2026804832 @default.
• W578040726 cites W2031655994 @default.
• W578040726 cites W2034639126 @default.
• W578040726 cites W2042606981 @default.
• W578040726 cites W2050354700 @default.
• W578040726 cites W2051207687 @default.
• W578040726 cites W2054091180 @default.
• W578040726 cites W2061333078 @default.
• W578040726 cites W2067099461 @default.
• W578040726 cites W2070295572 @default.
• W578040726 cites W2079869622 @default.
• W578040726 cites W2081898812 @default.
• W578040726 cites W2085636338 @default.
• W578040726 cites W2087841827 @default.
• W578040726 cites W2089314438 @default.
• W578040726 cites W2090058810 @default.
• W578040726 cites W2091232445 @default.
• W578040726 cites W2096429475 @default.
• W578040726 cites W2097643865 @default.
• W578040726 cites W2107032019 @default.
• W578040726 cites W2107789372 @default.
• W578040726 cites W2111258534 @default.
• W578040726 cites W2112778345 @default.
• W578040726 cites W2121289928 @default.
• W578040726 cites W2123652060 @default.
• W578040726 cites W2126485180 @default.
• W578040726 cites W2131266318 @default.
• W578040726 cites W2134823102 @default.
• W578040726 cites W2135910109 @default.
• W578040726 cites W2137482825 @default.
• W578040726 cites W2139322035 @default.
• W578040726 cites W2141819184 @default.
• W578040726 cites W2142604492 @default.
• W578040726 cites W2144213081 @default.
• W578040726 cites W2152883895 @default.
• W578040726 cites W2153153861 @default.
• W578040726 cites W2155283676 @default.
• W578040726 cites W2156616501 @default.
• W578040726 cites W2158337755 @default.
• W578040726 cites W2160205505 @default.
• W578040726 cites W2161344815 @default.
• W578040726 cites W2172257031 @default.
• W578040726 cites W2312837386 @default.
• W578040726 cites W84613431 @default.
• W578040726 doi "https://doi.org/10.1371/journal.pmed.1001833" @default.
• W578040726 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4452757" @default.
• W578040726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26035291" @default.
• W578040726 hasPublicationYear "2015" @default.
• W578040726 type Work @default.
• W578040726 sameAs 578040726 @default.
• W578040726 citedByCount "319" @default.
• W578040726 countsByYear W5780407262015 @default.
• W578040726 countsByYear W5780407262016 @default.
• W578040726 countsByYear W5780407262017 @default.

• next